DGAP-News: BKN BioKraftstoff Nord AG generates proceeds of EUR 5.5 million from capital increase

13.09.07 | 11:13 Uhr

BKN BioKraftstoff Nord AG / Capital Increase

13.09.2007

Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
---------------------------------------------------------------------------

BKN BioKraftstoff Nord AG generates proceeds of EUR 5.5 million from
capital increase

Sprakensehl-Bokel, September 12, 2007 - BKN BioKraftstoff Nord AG (German
Securities Code (WKN) A0LD4M, ISIN DE000A0LD4M4) has generated gross
proceeds totaling EUR 5.5 million as part of its capital increase from
authorized capital. A total of 500,000 new, no-par value bearer shares were
placed at a price of EUR 11.00. The additional equity is to be used in
particular to expand the high-growth biogas business and to pre-finance new
orders.

Around 25% of the capital increase was subscribed by existing shareholders
by exercising their subscription rights at a ratio of 5:1. Institutional
investors in Germany and abroad acquired the remaining 75% of the placement
volume. The free float has thus increased from 15.7% to 21.9%. BKN
BioKraftstoff Nord AG's share capital will increase from EUR 6,350,000 to
EUR 6,850,000 as a result of the issue of new shares.

After the capital increase has been entered in the commercial register
(scheduled for September 13, 2007), the new shares are expected to be
admitted to trading in the Entry Standard under ISIN DE000A0LD4M4 from
September 14, 2007. Ulrich Wogart, BKN BioKraftstoff Nord AG's CEO, drew a
positive conclusion: 'We have gained well-known new investors despite the
current difficult situation on the market and in the industry. This fresh
equity will allow us to consistently realize our growth targets - right on
time.'


This Corporate News and the information included therein are exclusively
for persons with domicile or place of business in the Federal Republic of
Germany. This information does not constitute an offer for sale in Germany
or in any other country, nor does it constitute a demand to purchase
securities of BKN BioKraftstoff Nord AG.


Company Profile

BKN BioKraftstoff Nord AG has specialized in project development for biogas
plants and the production of biodiesel. Thanks to BIOSTROM Energy Group AG
and its operating subsidiaries, which BKN successfully acquired in April,
BKN now operates successfully on the market for biogas plants as a prime
contractor, covering the entire value chain: The company has far-reaching
expertise from maintaining competitiveness standards for plant locations to
project planning, permit acquisition, construction and operation of biogas
plants as well as the efficient control of the plants. Biological process
control for biogas plants, supported by BIOSTROM's know-how, is one of its
particular assets.

BKN's subsidiary BioDiesel Bokel GmbH, which stemmed from an agricultural
distillery cooperative, currently has capacity to produce around 50,000
t/year of biodiesel. The company has already substantially increased its
revenues and earnings over the past few years.


cometis AG
Susanne Gremmler
T +49 (0)611.20585523
F +49 (0)611.20585566
gremmler@cometis.de



13.09.2007 Financial News transmitted by DGAP

---------------------------------------------------------------------------

Language: English
Issuer: BKN BioKraftstoff Nord AG
Bodenteicher Straße 8
29365 Sprakensehl-Bokel
Deutschland
Phone: +49 (0)5837- 14095-0
Fax: +49 (0)5837- 14095-20
E-mail: info@bkn-ag.de
Internet: www.bkn-ag.de
ISIN: DE000A0LD4M4
WKN: A0LD4M
Listed: Freiverkehr in Berlin, Düsseldorf, Stuttgart; Entry Standard
in Frankfurt

End of News DGAP News-Service

---------------------------------------------------------------------------